|
Reimbursement status of authorised biosimilars in MS and EFTA countries (Platform on access to medicines in Europe - Market access for biosimilars)
Dokumenta datums: Wed Apr 17 00:00:00 CEST 2013
- Sagatavoja ENTR.R.4
- Publicēšanas datums: Wed Nov 19 12:56:34 CET 2014
|
|
Initial investigation to assess the feasibility of a coordinated system to access orphan medicines
Dokumenta datums: Mon May 30 00:00:00 CEST 2011
- Sagatavoja ENTR.R.4
- Publicēšanas datums: Wed Nov 19 11:44:56 CET 2014
|
|
The Pharmaceutical Distribution Chain in the European Union: Structure and Impact on Pharmaceutical Prices
Dokumenta datums: Wed Mar 30 00:00:00 CEST 2011
- Sagatavoja ENTR.R.4
- Publicēšanas datums: Wed Nov 19 11:40:49 CET 2014
- Pēdējā atjaunināšana: Wed Nov 19 11:40:48 CET 2014
|
|
Experiences and Impact of European Risk-Sharing Schemes Focusing on Oncology Medicines
Dokumenta datums: Sun Jan 30 00:00:00 CET 2011
- Sagatavoja ENTR.R.4
- Publicēšanas datums: Wed Nov 19 11:30:46 CET 2014
- Pēdējā atjaunināšana: Wed Nov 19 11:30:45 CET 2014
|
|
Short- and Long-Term Effects of Value-Based Pricing vs. External Price Referencing
Dokumenta datums: Sat Jan 30 00:00:00 CET 2010
- Sagatavoja ENTR.R.4
- Publicēšanas datums: Wed Nov 19 11:36:07 CET 2014
- Pēdējā atjaunināšana: Wed Nov 19 11:36:06 CET 2014
|
|
Tender systems for outpatient pharmaceuticals in the European Union: Evidence from the Netherlands, Germany and Belgium
Dokumenta datums: Thu Oct 29 00:00:00 CET 2009
- Sagatavoja ENTR.R.4
- Publicēšanas datums: Wed Nov 19 11:25:52 CET 2014
- Pēdējā atjaunināšana: Wed Nov 19 11:25:51 CET 2014
|
|
Core principles on relative effectiveness (Pharmaceutical forum - Working Group on Relative Effectiveness)
Dokumenta datums: Mon Sep 01 00:00:00 CEST 2008
- Sagatavoja ENTR.R.4
- Publicēšanas datums: Wed Nov 19 08:28:56 CET 2014
- Pēdējā atjaunināšana: Wed Nov 19 08:28:55 CET 2014
|
|
Data availability to conduct on rel ative effectiven ess assessments (Pharmaceutical forum - Working Group on Relative Effectiveness)
Dokumenta datums: Mon Sep 01 00:00:00 CEST 2008
- Sagatavoja ENTR.R.4
- Publicēšanas datums: Wed Nov 19 08:32:19 CET 2014
- Pēdējā atjaunināšana: Wed Nov 19 08:32:18 CET 2014
|
|
Development of networking and collaboration (Pharmaceutical forum - Working Group on Relative Effectiveness)
Dokumenta datums: Mon Sep 01 00:00:00 CEST 2008
- Sagatavoja ENTR.R.4
- Publicēšanas datums: Wed Nov 19 08:35:13 CET 2014
- Pēdējā atjaunināšana: Wed Nov 19 08:35:12 CET 2014
|
|
Guiding principles for good practices implementing a pricing and reimbursement policy (Pharmaceutical forum - Working Group on Pricing and Reimbursement)
Dokumenta datums: Mon Sep 01 00:00:00 CEST 2008
- Sagatavoja ENTR.R.4
- Publicēšanas datums: Wed Nov 19 08:42:31 CET 2014
|
|
Ensuring availability of medicines in small national markets (Pharmaceutical forum - Working Group on Pricing and Reimbursement)
Dokumenta datums: Mon Sep 01 00:00:00 CEST 2008
- Sagatavoja ENTR.R.4
- Publicēšanas datums: Wed Nov 19 08:45:53 CET 2014
|
|
Improving access to orphan medicines for all affected EU citizens (Pharmaceutical forum - Working Group on Pricing and Reimbursement)
Dokumenta datums: Mon Sep 01 00:00:00 CEST 2008
- Sagatavoja ENTR.R.4
- Publicēšanas datums: Wed Nov 19 08:49:27 CET 2014
- Pēdējā atjaunināšana: Wed Nov 19 08:49:26 CET 2014
|
|
From assessing innovative value of pharmaceuticals to pricing and reimbursement decisions (Pharmaceutical forum - Working Group on Pricing and Reimbursement)
Dokumenta datums: Mon Sep 01 00:00:00 CEST 2008
- Sagatavoja ENTR.R.4
- Publicēšanas datums: Wed Nov 19 08:56:26 CET 2014
- Pēdējā atjaunināšana: Wed Nov 19 08:56:25 CET 2014
|
|
Characterisation of the Value of Innovative Medicines (Pharmaceutical forum - Working Group on Pricing and Reimbursement)
Dokumenta datums: Mon Sep 01 00:00:00 CEST 2008
- Sagatavoja ENTR.R.4
- Publicēšanas datums: Wed Nov 19 08:52:18 CET 2014
|
|
Building a toolbox of good practices to control budget, ensure access and rewards innovation (Pharmaceutical forum - Working Group on Pricing and Reimbursement)
Dokumenta datums: Mon Sep 01 00:00:00 CEST 2008
- Sagatavoja ENTR.R.4
- Publicēšanas datums: Wed Nov 19 08:59:09 CET 2014
|
|
Risk-Sharing practices and Conditional Pricing of pharmaceuticals - How to deal with uncertainty - Some EU Member State practices (Pharmaceutical forum - Working Group on Pricing and Reimbursement)
Dokumenta datums: Mon Sep 01 00:00:00 CEST 2008
- Sagatavoja ENTR.R.4
- Publicēšanas datums: Wed Nov 19 09:02:46 CET 2014
|
|
Project: Pharmaceutical Pricing and Reimbursement Information
Dokumenta datums: Sun Jun 29 00:00:00 CEST 2008
- Sagatavoja ENTR.R.4
- Publicēšanas datums: Wed Nov 19 11:15:32 CET 2014
Novirzīt uz: http://ppri.oebig.at/
|
|
Surveying, Assessing and Analysing the Pharmaceutical Sector in the 25 EU Member States
Dokumenta datums: Sun Jul 30 00:00:00 CEST 2006
- Sagatavoja ENTR.R.4
- Publicēšanas datums: Wed Nov 19 10:55:59 CET 2014
- Pēdējā atjaunināšana: Wed Nov 19 10:55:58 CET 2014
|
